BDX - Becton, Dickinson and Co. -  [ ]

Ticker Details
Becton, Dickinson and Co.
Becton, Dickinson and Co is a healthcare company. It manufacture and sales medical supplies, devices, laboratory equipment and diagnostic products. It operates in two segments BD Medical and BD Life Sciences.
IPO Date: January 2, 1990
Sector: Healthcare
Industry: Health Care Equipment and Supplies
Market Cap: $40.68B
Activated in VL: True
Average Daily Range
Avg Daily Range: $2.00 | 0.85%
Avg Daily Range (30 D): $1.98 | 1.32%
Avg Daily Range (90 D): $1.89 | 1.13%
Institutional Daily Volume
Avg Daily Volume: 1.17M
Avg Daily Volume (30 D): 2.63M
Avg Daily Volume (90 D): 2.29M
Trade Size
Avg Trade Size (Sh.): 84
Avg Trade Size (Sh.) (30 D): 57
Avg Trade Size (Sh.) (90 D): 53
Institutional Trades
Total Institutional Trades: 28,361
Avg Institutional Trade: $8.07M
Avg Institutional Trade (30 D): $12.9M
Avg Institutional Trade (90 D): $16.34M
Avg Institutional Trade Volume: .05M
Avg Institutional Trades (Per Day): 4
Market Closing Trades
Avg Closing Trade: $28.74M
Avg Closing Trade (30 D): $70.8M
Avg Closing Trade (90 D): $68.95M
Avg Closing Volume: 144.21K
 
News
May 26, 2026 @ 3:30 AM
Microneedle Drug Delivery Systems Market to Hit US...
Source: Sns Insider
May 25, 2026 @ 9:15 PM
Why Johnson & Johnson Might Be the Smartest Divide...
Source: Reuben Gregg Brewer
May 19, 2026 @ 8:54 AM
Nebulizers - Global Strategic Business Report 2026...
Source: Researchandmarkets.Com
May 14, 2026 @ 5:00 PM
Global Cervical Cancer Diagnostics Market to Exhib...
Source: Delveinsight
May 12, 2026 @ 5:00 PM
Global HPV Testing and Pap Test Market is Expected...
Source: Delveinsight
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $3.95 $-1.11 $1.34
Diluted EPS $3.95 $-1.11 $1.34
Revenue $21.37B $4.71B $5.25B
Gross Profit $10B $2.15B $2.41B
Net Income / Loss $1.14B $-311M $382M
Operating Income / Loss $2.22B $93M $552M
Cost of Revenue $11.37B $2.56B $2.84B
Net Cash Flow $344M $64M $174M
PE Ratio